×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FENC – fennec pharmaceuticals inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FENC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/16
09:47 am
fenc
Adherex Technologies (FENC) had its "outperform" rating reaffirmed by Wedbush. They now have a $13.00 price target on the stock.
Medium
Report
Adherex Technologies (FENC) had its "outperform" rating reaffirmed by Wedbush. They now have a $13.00 price target on the stock.
4/7
07:03 am
fenc
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Low
Report
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
3/31
06:17 am
fenc
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/31
06:00 am
fenc
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/27
07:25 am
fenc
Adherex Technologies (FENC) was downgraded by Zacks Research from "hold" to "strong sell".
High
Report
Adherex Technologies (FENC) was downgraded by Zacks Research from "hold" to "strong sell".
3/24
03:21 pm
fenc
Fennec Pharmaceuticals Inc (FENC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
Low
Report
Fennec Pharmaceuticals Inc (FENC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
3/24
07:32 am
fenc
Fennec Pharmaceuticals GAAP EPS of -$0.17 misses by $0.21, revenue of $13.78M misses by $0.95M [Seeking Alpha]
High
Report
Fennec Pharmaceuticals GAAP EPS of -$0.17 misses by $0.21, revenue of $13.78M misses by $0.95M [Seeking Alpha]
3/24
07:00 am
fenc
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
High
Report
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Date
Time
Symbol
Company Name
Action
%Chg
3/24/2026
07:00 am
FENC
fennec pharmaceuticals inc.
MISS
Report
-20.4%
fennec pharmaceuticals inc.
11/13/2025
04:01 pm
FENC
fennec pharmaceuticals inc.
BEAT
Report
3.8%
fennec pharmaceuticals inc.
8/14/2025
06:08 am
FENC
fennec pharmaceuticals inc.
MISS
Report
-7.8%
fennec pharmaceuticals inc.
5/13/2025
06:03 am
FENC
fennec pharmaceuticals inc.
BEAT
Report
-0.5%
fennec pharmaceuticals inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/7
04:27 pm
fenc
Form 8-K FENNEC PHARMACEUTICALS For: Apr 07
Low
Report
Form 8-K FENNEC PHARMACEUTICALS For: Apr 07
4/2
04:06 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Sayad Pierre Sargis
Neutral
Report
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Sayad Pierre Sargis
4/2
04:06 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Mar 31 Filed by: Raykov Rosty
Neutral
Report
Form 4 FENNEC PHARMACEUTICALS For: Mar 31 Filed by: Raykov Rosty
4/2
04:06 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Andrade Robert
Neutral
Report
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Andrade Robert
4/2
04:06 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Hackman Jeffrey S.
Neutral
Report
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Hackman Jeffrey S.
4/2
04:06 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Cioffi Christiana Marie
Neutral
Report
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Cioffi Christiana Marie
4/2
04:06 pm
fenc
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Evans Terry L
Neutral
Report
Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Evans Terry L
4/1
04:38 pm
fenc
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
Low
Report
Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/13
Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug Application for PEDMARK™
11.9%
3/5 Form 8-K FENNEC PHARMACEUTICALS For: Mar 05 8.0%
2/11 Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency 7.8%
7/30 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
12/23 Hedge Funds Aren’t Crazy About Contango Oil & Gas Company (MCF) Anymore [Yahoo! Finance News] 3.7%
2/14 Q4/2019 12/31/2019 EPS -0.180 ZacksConsensus N/A ActVsEst N/A - N/A 3.6%
5/16 Form DEF 14A FENNEC PHARMACEUTICALS For: Jun 18 1.9%
2/18 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. 1.7%
5/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 1.7%
4/30 Fennec Announces Pricing of Public Offering 1.6%
3/5 Form 8-K FENNEC PHARMACEUTICALS For: Mar 05 8.0%
2/11 Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency 7.8%
7/30 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
12/23 Hedge Funds Aren’t Crazy About Contango Oil & Gas Company (MCF) Anymore [Yahoo! Finance News] 3.7%
2/14 Q4/2019 12/31/2019 EPS -0.180 ZacksConsensus N/A ActVsEst N/A - N/A 3.6%
5/16 Form DEF 14A FENNEC PHARMACEUTICALS For: Jun 18 1.9%
2/18 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. 1.7%
5/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 1.7%
4/30 Fennec Announces Pricing of Public Offering 1.6%
TOP News Decliners
4/29
Fennec Announces Proposed Public Offering of Common Shares
-13.6%
4/15 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -11.9%
6/19 Fennec Announces Results of Annual Meeting -8.0%
4/7 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.7%
1/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.9%
4/13 Form 8-K FENNEC PHARMACEUTICALS For: Apr 13 -3.9%
12/2 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -3.7%
5/9 Form 8-K FENNEC PHARMACEUTICALS For: May 09 -2.6%
6/26 Form S-8 FENNEC PHARMACEUTICALS -2.4%
11/12 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.230 ActVsEst 0.140 - Beat -2.0%
4/15 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -11.9%
6/19 Fennec Announces Results of Annual Meeting -8.0%
4/7 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.7%
1/14 Fennec Pharmaceuticals Inc (NASDAQ: FENC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.9%
4/13 Form 8-K FENNEC PHARMACEUTICALS For: Apr 13 -3.9%
12/2 Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock. -3.7%
5/9 Form 8-K FENNEC PHARMACEUTICALS For: May 09 -2.6%
6/26 Form S-8 FENNEC PHARMACEUTICALS -2.4%
11/12 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.230 ActVsEst 0.140 - Beat -2.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: